HomeTagsVAR002

VAR002

Healthcare

VARIANT Receives European Orphan Drug Designation for its Gene Therapy Product Candidate, VAR002, for the Treatment of Both Leber Congenital Amaurosis and Cone-Rod dystrophy

Business Wire - November 27, 2021

Variant, a company dedicated to developing innovative treatments for inherited eye orphan diseases, announces the decision of the European Commission to grant Orphan Drug...

Hot Topics

What Is Multimodal Transportation? A Guide for Modern Supply Chains

BAE Systems Launches Rapid Capability Kits Installations for U.S. Defense

Destinus acquires Daedalean to strengthen AI for Autonomous Flight